Latest Medical laboratory Stories
MUNDELEIN, Ill., March 20, 2012 /PRNewswire/ -- Sysmex America, Inc., a global leader in medical diagnostic testing equipment and information systems technology, today announced its 200th placement of Sysmex WAM(TM) Decision Support Software for the Clinical Laboratory. Sysmex WAM is now connecting nearly 600 sites and approximately 1,000 instruments in clinical laboratories across the U.S. and Canada. Sysmex WAM plays a key role in delivering leading-edge functionality that helps...
Millennium's vigorous support of legislation helps move state closer to cleaning up abusive practices in lab industry; flagrant violators are "out of options and must comply" SAN DIEGO, March 10, 2012 /PRNewswire-USNewswire/ -- Millennium Laboratories praised the Florida legislature for sending SB 1292 to Governor Rick Scott for signature after it passed with overwhelming margins in both Houses. The law addresses a comprehensive list of issues related to the Florida Agency for...
FT. MYERS, Fla., March 5, 2012 /PRNewswire/ -- NeoGenomics, Inc. (NASD OTCQB: NGNM) announced today that it was revising upward its previously issued revenue guidance for the first quarter of 2012. The Company now expects revenue of approximately $14.5 - $15.0 million for the first quarter, an increase from the prior guidance of $13.5 - $14.0 million released on February 16, 2012. At the $14.75 million midpoint of this revised guidance range, first quarter revenue would be 68%...
BRANFORD, Conn., Feb. 21, 2012 /PRNewswire/ -- HistoRx, the leader in quantitative immunohistochemistry (IHC), advances its proprietary position in measurement of biomarkers in tissue through today's issuance of US Patent 8,121,365 protecting the company's "Methods and systems for determining optimal dilution of a reagent." As the first in what HistoRx expects will be a series of broadening patents pertaining to its quantitative methodology, this patent protects the company's...
Advance Dx, Inc. newly patented serum separating blood collection card to enhance efforts to screen all Americans for early disease detection. Chicago, IL (PRWEB) January 19, 2012 Advance Dx, Inc. announced the issuance of US Patent No. 8,062,608 from the US Patent office, which relates to the ADx 100 serum separating blood collection card for use by the clinical laboratory industry. This marks the first time such a patented collection device has been made available for all laboratories....
ALISO VIEJO, Calif., Jan. 19, 2012 /PRNewswire/ -- Ambry Genetics, a global leader in genetic services with a focus on clinical diagnostics and genomics, announces the successful completion of the first three diagnostic cases using its proprietary Clinical Diagnostic Exome(TM). Three individuals suffering from symptoms for which the cause could not be identified were successfully diagnosed. (Logo: http://photos.prnewswire.com/prnh/20110307/LA59848LOGO) "This marks a...
UNION CITY, Calif., Jan. 17, 2012 /PRNewswire/ -- Abaxis, Inc. (NasdaqGS: ABAX), a medical products company manufacturing point-of-care blood analysis systems, has scheduled a conference call to discuss its financial results for the third quarter of fiscal year 2012, ended December 31, 2011. The call will be at 4:15 p.m. ET on Thursday, January 26, 2012. The Company will report financial results for the third quarter of fiscal 2012 after the market closes on Thursday, January 26,...
FT. MYERS, Fla., Jan. 9, 2012 /PRNewswire/ -- NeoGenomics, Inc. (NASD OTC BB: NGNM), a leading provider of cancer-focused genetic testing services, announced today the appointment of Dr. Maher Albitar as Chief Medical Officer and Director of Research and Development. From 2003 to 2010, Dr. Albitar served as the Medical Director for Hematopathology and Oncology, and Chief of Research and Development, for Quest Diagnostics Nichols Institute. He was responsible for the development of...
FT. MYERS, Fla., Jan. 9, 2012 /PRNewswire/ -- NeoGenomics, Inc. (NASD OTC BB: NGNM), a leading provider of cancer-focused genetic testing services, announced today that it has licensed from Health Discovery Corporation ("HDC", OTCBB: HDVY) the exclusive worldwide rights to utilize HDC's extensive intellectual property portfolio to develop laboratory developed tests ("LDTs") and other products relating to hematopoietic and solid tumor cancers. HDC owns intellectual property and know...
SAN DIEGO, Jan. 6, 2012 /PRNewswire/ -- TrovaGene, Inc. (Pink Sheets: TROV.PK), a developer of trans-renal molecular diagnostics, today announced that it has entered into a definitive agreement to acquire MultiGEN Diagnostics, Inc.'s ('MultiGEN') clinical laboratory assets in exchange for the issuance of 750,000 shares of common stock of TrovaGene, with an additional earn-out of up to $3.7 million in cash and common stock, subject to the achievement of specific sales and earnings...
